Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 24, 2012 - Issue 4
981
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Does the use of ingredients added to tobacco increase cigarette addictiveness?: A detailed analysis

, , &
Pages 227-245 | Received 08 Dec 2011, Accepted 30 Jan 2012, Published online: 20 Mar 2012

References

  • Abelin T, Buehler A, Müller P, Vesanen K, Imhof PR. 1989. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1:7–10.
  • Ahluwalia JS, Okuyemi K, Nollen N, Choi WS, Kaur H, Pulvers K, Mayo MS. 2006. The effects of nicotine gum and counseling among African American light smokers: a 2 × 2 factorial design. Addiction 101:883–891.
  • ASH, 2011. Ash fact sheets. The UK Tobacco Industry. Available at: http//www.ash.org.UK/files/documents_ASH123.pdf
  • Biggs D, de Ville B, Suena E. 1991. A method of choosing multiway partitions for classification and decision trees. J Appl Statist, 18: 49–62.
  • Binnie VI, McHugh S, Jenkins W, Borland W, Macpherson LM. 2007. A randomised controlled trial of a smoking cessation intervention delivered by dental hygienists: a feasibility study. BMC Oral Health 7:5.
  • Blöndal T. 1989. Controlled trial of nicotine polacrilex gum with supportive measures. Arch Intern Med 149:1818–1821.
  • Blöndal T, Franzon M, Westin A. 1997. A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. Eur Respir J 10:1585–1590.
  • British Thoracic Society. 1983. Comparison of four methods of smoking withdrawal in patients with smoking related diseases. BMJ, 286: 595–597.
  • Campbell IA, Lyons E, Prescott RJ. 1987. Stopping smoking. Do nicotine chewing-gum and postal encouragement add to doctors’ advice. Practitioner 231:114–117.
  • Campbell IA, Prescott RJ, Tjeder-Burton SM. 1991. Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum. Respir Med 85:155–157.
  • Campbell IA, Prescott RJ, Tjeder-Burton SM. 1996. Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. Respir Med 90:47–51.
  • Cinciripini PM, Cinciripini LG, Wallfisch A, Haque W, Van Vunakis H. 1996. Behavior therapy and the transdermal nicotine patch: effects on cessation outcome, affect, and coping. J Consult Clin Psychol 64:314–323.
  • Cooper TV, Klesges RC, Debon MW, Zbikowski SM, Johnson KC, Clemens LH. 2005. A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women. Addict Behav 30:61–75.
  • Dautzenberg B, Nides M, Kienzler JL, Callens A. 2007. Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell). BMC Clin Pharmacol 7:11.
  • Dautzenberg B, Peiffer G, Toulouse F, Yvinec MJ, Jacob N, Kienzler J. 2001. Randomized trial assessment of nicotine lozenge 1 mg, a new oral nicotine replacement therapy. Abstract Book, Society for Research on Nicotine and Tobacco Third International Conference, Paris, 55.
  • Davis DL and Nielsen MT 2007. Tobacco: Production, Chemistry and Technology. Oxford, UK: Blackwell Publishing.
  • Ehrsam RE, Bühler A, Müller P, Mauli D, Schumacher PM, Howald H, Imhof PR. 1991. [Weaning of young smokers using a transdermal nicotine patch]. Schweiz Rundsch Med Prax 80:145–150.
  • European Commission Health & Consumer Protection Directorate, 2007. Reporting on tobacco product ingredients. Practical Guide. European Commission, Brussels.
  • Fagerström KO. 1982. A comparison of psychological and pharmacological treatment in smoking cessation. J Behav Med 5:343–351.
  • Fagerström KO. 1984. Effects of nicotine chewing gum and follow-up appointments in physician-based smoking cessation. Prev Med 13:517–527.
  • Fiore MC, Kenford SL, Jorenby DE, Wetter DW, Smith SS, Baker TB. 1994. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest 105:524–533.
  • Fortmann SP, Killen JD. 1995. Nicotine gum and self-help behavioral treatment for smoking relapse prevention: results from a trial using population-based recruitment. J Consult Clin Psychol 63:460–468.
  • Garvey AJ, Kinnunen T, Nordstrom BL, Utman CH, Doherty K, Rosner B, Vokonas PS. 2000. Effects of nicotine gum dose by level of nicotine dependence. Nicotine Tob Res 2:53–63.
  • Gilbert JR, Wilson DM, Best JA, Taylor DW, Lindsay EA, Singer J, Willms DG. 1989. Smoking cessation in primary care. A randomized controlled trial of nicotine-bearing chewing gum. J Fam Pract 28:49–55.
  • Glavas D, Rumboldt M, Rumboldt Z. 2003a. Smoking cessation with nicotine replacement therapy among health care workers: randomized double-blind study. Croat Med J 44:219–224.
  • Glavas D, Rumboldt Z. 2003b. [Smoking cessation using the transdermal nicotine system]. Lijec Vjesn 125:8–12.
  • Glover ED, Glover PN, Franzon M, Sullivan CR, Cerullo CC, Howell RM, Keyes GG, Nilsson F, Hobbs GR. 2002. A comparison of a nicotine sublingual tablet and placebo for smoking cessation. Nicotine Tob Res 4:441–450.
  • Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ. 1995. Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ 311:363–366.
  • Gross J, Johnson J, Sigler L, Stitzer ML. 1995. Dose effects of nicotine gum. Addict Behav 20:371–381.
  • Hall SM, Tunstall C, Rugg D, Jones RT, Benowitz N. 1985. Nicotine gum and behavioral treatment in smoking cessation. J Consult Clin Psychol 53:256–258.
  • Hall SM, Tunstall CD, Ginsberg D, Benowitz NL, Jones RT. 1987. Nicotine gum and behavioral treatment: a placebo controlled trial. J Consult Clin Psychol 55:603–605.
  • Hand S, Edwards S, Campbell IA, Cannings R. 2002. Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support. Thorax 57:715–718.
  • Harackiewicz JM, Blair LW, Sansone C, Epstein JA, Stuchell RN. 1988. Nicotine gum and self-help manuals in smoking cessation: an evaluation in a medical context. Addict Behav 13:319–330.
  • Hays JT, Croghan IT, Schroeder DR, Offord KP, Hurt RD, Wolter TD, Nides MA, Davidson M. 1999. Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. Am J Public Health 89:1701–1707.
  • Henningfield JE, Benowitz NL, Connolly GN, Davis RM, Gray N, Myers ML, Zeller M. 2004. Reducing tobacco addiction through tobacco product regulation. Tob Control 13:132–135.
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ 327:557–560.
  • Hilberink SR, Jacobs JE, Breteler MH, de Vries H, Grol RP. 2011. General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: impact after 1 year of two complex interventions. Patient Educ Couns 83:120–124.
  • Hjalmarson AI. 1984. Effect of nicotine chewing gum in smoking cessation. A randomized, placebo-controlled, double-blind study. JAMA 252:2835–2838.
  • Hjalmarson A, Franzon M, Westin A, Wiklund O. 1994. Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study. Arch Intern Med 154:2567–2572.
  • Hjalmarson A, Nilsson F, Sjöström L, Wiklund O. 1997. The nicotine inhaler in smoking cessation. Arch Intern Med 157:1721–1728.
  • Hughes JR, Gust SW, Keenan RM, Fenwick JW, Healey ML. 1989. Nicotine vs placebo gum in general medical practice. JAMA 261:1300–1305.
  • Hughes JR, Novy P, Hatsukami DK, Jensen J, Callas PW. 2003. Efficacy of nicotine patch in smokers with a history of alcoholism. Alcohol Clin Exp Res 27:946–954.
  • Hurt RD, Lauger GG, Offord KP, Kottke TE, Dale LC. 1990. Nicotine-replacement therapy with use of a transdermal nicotine patch–a randomized double-blind placebo-controlled trial. Mayo Clin Proc 65:1529–1537.
  • Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, Lauger GG, Marusic Z, Neese LW, Lundberg TG. 1994. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. JAMA 271:595–600.
  • Imperial Cancer Research Fund General Practice Group. 1994. Randomised trial of nicotine patches in general practice: results at one year. BMJ, 308: 1476–1477.
  • Jamrozik K, Fowler G, Vessey M, Wald N. 1984. Placebo controlled trial of nicotine chewing gum in general practice. Br Med J (Clin Res Ed) 289:794–797.
  • Jarvis MJ, Raw M, Russell MA, Feyerabend C. 1982. Randomised controlled trial of nicotine chewing-gum. Br Med J (Clin Res Ed) 285:537–540.
  • Jensen EJ, Schmidt E, Pedersen B, Dahl R. 1991. The effect of nicotine, silver acetate, and placebo chewing gum on the cessation of smoking. The influence of smoking type and nicotine dependence. Int J Addict 26:1223–1231.
  • Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB. 1999. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685–691.
  • Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, Sherman SE, Cleveland M, Antonuccio DO, Antonnucio DO, Hartman N, McGovern PG. 1996. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 335:1792–1798.
  • Killen JD, Maccoby N, Taylor CB. 1984. Nicotine gum and self-regulation training in smoking relapse prevention. Behav Ther, 15: 234–248.
  • Killen JD, Fortmann SP, Newman B, Varady A. 1990. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 58:85–92.
  • Killen JD, Fortmann SP, Davis L, Varady A. 1997. Nicotine patch and self-help video for cigarette smoking cessation. J Consult Clin Psychol 65:663–672.
  • Kinnunen T, Korhonen T, Garvey AJ. 2008. Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: twelve-month results of a randomized placebo controlled trial. Int J Psychiatry Med 38:373–389.
  • Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. 1995. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 24:41–47.
  • Kralikova E, Kozak J, Rasmussen T, Cort N. 2002. The clinical benefits of NRT-supported smoking reduction. Nicotine Tob Res, 4, 243.
  • Kralikova E, Kozak JT, Rasmussen T, Gustavsson G, Le Houezec J. 2009. Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler. BMC Public Health 9:433.
  • Lee PN, Forey BA, Fry JS, Hamling JS, Hamling JF, Sanders EB, Carchman RA. 2009. Does use of flue-cured rather than blended cigarettes affect international variation in mortality from lung cancer and COPD? Inhal Toxicol 21:404–430.
  • Leischow SJ, Nilsson F, Franzon M, Hill A, Otte P, Merikle EP. 1996. Efficacy of the nicotine inhaler as an adjunct to smoking cessation. Am J Health Behav, 20: 364–371.
  • Lewis SF, Piasecki TM, Fiore MC, Anderson JE, Baker TB. 1998. Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. Prev Med 27:296–303.
  • Malcolm RE, Sillett RW, Turner JA, Ball KP. 1980. The use of nicotine chewing gum as an aid to stopping smoking. Psychopharmacology (Berl) 70:295–296.
  • McGovern PG, Lando HA. 1992. An assessment of nicotine gum as an adjunct to freedom from smoking cessation clinics. Addict Behav 17:137–147.
  • Molyneux A, Lewis S, Leivers U, Anderton A, Antoniak M, Brackenridge A, Nilsson F, McNeill A, West R, Moxham J, Britton J. 2003. Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax 58:484–488.
  • Moolchan ET, Robinson ML, Ernst M, Cadet JL, Pickworth WB, Heishman SJ, Schroeder JR. 2005. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics 115:e407–e414.
  • Müller P, Abelin T, Ehrsam R, Imhof P, Howald H, Mauli D. 1990. The use of transdermal nicotine in smoking cessation. Lung 168 Suppl:445–453.
  • Niaura R, Abrams DB, Shadel WG, Rohsenow DJ, Monti PM, Sirota AD. 1999. Cue exposure treatment for smoking relapse prevention: a controlled clinical trial. Addiction 94:685–695.
  • Okuyemi KS, James AS, Mayo MS, Nollen N, Catley D, Choi WS, Ahluwalia JS. 2007. Pathways to health: a cluster randomized trial of nicotine gum and motivational interviewing for smoking cessation in low-income housing. Health Educ Behav, 34: 43–54.
  • Oncken C, Cooney J, Feinn R, Lando H, Kranzler HR. 2007. Transdermal nicotine for smoking cessation in postmenopausal women. Addict Behav 32:296–309.
  • Oncken C, Dornelas E, Greene J, Sankey H, Glasmann A, Feinn R, Kranzler HR. 2008. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol 112:859–867.
  • Paoletti P, Fornai E, Maggiorelli F, Puntoni R, Viegi G, Carrozzi L, Corlando A, Gustavsson G, Säwe U, Giuntini C. 1996. Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch. Eur Respir J 9:643–651.
  • Pirie PL, McBride CM, Hellerstedt W, Jeffery RW, Hatsukami D, Allen S, Lando H. 1992. Smoking cessation in women concerned about weight. Am J Public Health 82:1238–1243.
  • Petitti DB. 2000. Meta-analysis, decision analysis, and cost effective analysis methods for quantitative synthesis in medicine. In Monographs in epidemiology and biostatistics, Second edition, New York: Oxford University Press.
  • Pollak KI, Oncken CA, Lipkus IM, Lyna P, Swamy GK, Pletsch PK, Peterson BL, Heine RP, Brouwer RJ, Fish L, Myers ER. 2007. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med 33:297–305.
  • Prapavessis H, Cameron L, Baldi JC, Robinson S, Borrie K, Harper T, Grove JR. 2007. The effects of exercise and nicotine replacement therapy on smoking rates in women. Addict Behav 32:1416–1432.
  • Puska P, Oorhonen HJ, Vartianen E, Urjanheimo EL, Gustavsson G, Westin A. 1995. Combined use of nicotine patch and gum compared with gum alone in smoking cessation: a clinical trial in North Karelia. Tob Control, 4: 231–235.
  • Quílez García C, Hernando Arizaleta L, Rubio Díaz A, Granero Fernández EJ, Vila Coll MA, Estruch Riba J. 1989. [Double-blind study of the efficacy of nicotine chewing gum for smoking cessation in the primary care setting]. Aten Primaria 6:719–726.
  • Rennard SI, Glover ED, Leischow S, Daughton DM, Glover PN, Muramoto M, Franzon M, Danielsson T, Landfeldt B, Westin A. 2006. Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial. Nicotine Tob Res 8:555–564.
  • Richmond RL, Makinson RJ, Kehoe LA, Giugni AA, Webster IW. 1993. One-year evaluation of three smoking cessation interventions administered by general practitioners. Addict Behav 18:187–199.
  • Richmond RL, Harris K, de Almeida Neto A. 1994. The transdermal nicotine patch: results of a randomised placebo-controlled trial. Med J Aust 161:130–135.
  • Russell MA, Merriman R, Stapleton J, Taylor W. 1983. Effect of nicotine chewing gum as an adjunct to general practitioner’s advice against smoking. Br Med J (Clin Res Ed) 287:1782–1785.
  • Sachs DP, Säwe U, Leischow SJ. 1993. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med 153:1881–1890.
  • Salvador Llivina T, Marín Tuyà D, González Quintana J, Iniesta Torres C, Castellví Barrera E, Muriana Sáez C, Agustí Vidal A. 1988. [Treatment of smoking: efficacy of the use of nicotine chewing gum. Double-blind study]. Med Clin (Barc) 90:646–650.
  • SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). 2010. Addictiveness and Attractiveness of Tobacco Additives, November 2010.
  • Schmelzle J, Rosser WW, Birtwhistle R. 2008. Update on pharmacologic and nonpharmacologic therapies for smoking cessation. Can Fam Physician 54:994–999.
  • Schneider NG, Jarvik ME, Forsythe AB, Read LL, Elliott ML, Schweiger A. 1983. Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial. Addict Behav 8:253–261.
  • Schneider NG, Olmstead R, Mody FV, Doan K, Franzon M, Jarvik ME, Steinberg C. 1995. Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction 90:1671–1682.
  • Schneider NG, Olmstead R, Nilsson F, Mody FV, Franzon M, Doan K. 1996. Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction 91:1293–1306.
  • Schwartz JL. 1979. Review and evaluation of methods of smoking cessation, 1969-77. Summary of a monograph. Public Health Rep 94:558–563.
  • Segnan N, Ponti A, Battista RN, Senore C, Rosso S, Shapiro SH, Aimar D. 1991. A randomized trial of smoking cessation interventions in general practice in Italy. Cancer Causes Control 2:239–246.
  • Select Committee on Health of the UK Houses of Parliament, 2000. Second report of the Select Committee on Health of the UK Houses of Parliament. The tobacco industry and the health risks of smoking. Appendices to the Minutes of Evidence.
  • Shiffman S, Ferguson SG, Strahs KR. 2009. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. Am J Prev Med 36:96–104.e1.
  • Stapleton JA, Russell MA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, Wiseman D. 1995. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 90:31–42.
  • Stead JF, Perera R, Bullen C, Mant D, Lancaster T. 2008. Nicotine replacement therapy for smoking cessation (review). Cochrane Database Syst Rev, 1: CD000146.
  • Stookey GK, Katz BP, Olson BL, Drook CA, Cohen SJ. 1987. Evaluation of biochemical validation measures in determination of smoking status. J Dent Res 66:1597–1601.
  • Strobl C, Malley J, Tutz G. 2009. An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. Psychol Methods 14:323–348.
  • Sutherland G, Stapleton JA, Russell MA, Jarvis MJ, Hajek P, Belcher M, Feyerabend C. 1992. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 340:324–329.
  • Tønnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer H, Stockner M. 1988. Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med 318:15–18.
  • Tønnesen P, Nørregaard J, Simonsen K, Säwe U. 1991. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 325:311–315.
  • Tønnesen P, Nørregaard J, Mikkelsen K, Jørgensen S, Nilsson F. 1993. A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 269:1268–1271.
  • Tønnesen P, Mikkelsen K, Bremann L. 2006. Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest 130:334–342.
  • Transdermal Nicotine Study Group. 1991. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA, 266: 3133–3138.
  • U.S. Department of Health and Human Services. 2010. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
  • U.S. Department of Health and Human Services. 2003. NCI Smoking and Control Monograph 15. Those Who Continue to Smoke. Is Achieving Abstinence Harder and Do We Need to Change Our Interventions? National Institutes of Health, National Cancer Institute. Chapter 1, p. 16.
  • Wallace BC, Schmid CH, Lau J, Trikalinos TA. 2009. Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 9:80.
  • Wallström M, Nilsson F, Hirsch JM. 2000. A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction 95:1161–1171.
  • Westman EC, Levin ED, Rose JE. 1993. The nicotine patch in smoking cessation. A randomized trial with telephone counseling. Arch Intern Med 153:1917–1923.
  • Wewers ME, Ferketich AK, Harness J, Paskett ED. 2009. Effectiveness of a nurse-managed, lay-led tobacco cessation intervention among ohio appalachian women. Cancer Epidemiol Biomarkers Prev 18:3451–3458.